Susquehanna Fundamental Investments, LLC Xencor Inc Call Options Transaction History
Susquehanna Fundamental Investments, LLC
- $4.33 Trillion
- Q2 2024
Call Options
0 transactions
| Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
|---|
Others Institutions Holding XNCR
# of Institutions
202Shares Held
63.3MCall Options Held
3.9KPut Options Held
3K-
Black Rock Inc. New York, NY11.1MShares$262 Million0.0% of portfolio
-
Primecap Management CO Pasadena, CA9.14MShares$216 Million0.14% of portfolio
-
Vanguard Group Inc Valley Forge, PA7MShares$165 Million0.0% of portfolio
-
Eco R1 Capital, LLC San Francisco, CA5.33MShares$126 Million3.57% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD3.96MShares$93.6 Million0.01% of portfolio
About Xencor Inc
- Ticker XNCR
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 59,698,100
- Market Cap $1.41B
- Description
- Xencor, Inc., a clinical stage biopharmaceutical company, focuses on the discovery and development of engineered monoclonal antibody and cytokine therapeutics to treat patients with cancer and autoimmune diseases. The company provides Sotrovimab that targets the SARS-CoV-2 virus; Ultomiris for the treatment of patients with paroxysmal nocturnal ...